Kento Umino

568 total citations
23 papers, 148 citations indexed

About

Kento Umino is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Kento Umino has authored 23 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Kento Umino's work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Kento Umino is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Kento Umino collaborates with scholars based in Japan. Kento Umino's co-authors include Kazuya Sato, Yoshinobu Kanda, Shin‐ichiro Fujiwara, Kaoru Hatano, Kiyomi Mashima, Ken Ohmine, Chihiro Yamamoto, Miyuki Sugimoto, Yasufumi Kawasaki and Ryoko Yamasaki and has published in prestigious journals such as Blood, The Journal of Immunology and Bone Marrow Transplantation.

In The Last Decade

Kento Umino

22 papers receiving 146 citations

Peers

Countries citing papers authored by Kento Umino

Since Specialization

Citations

This map shows the geographic impact of Kento Umino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kento Umino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kento Umino more than expected).

Fields of papers citing papers by Kento Umino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kento Umino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kento Umino. The network helps show where Kento Umino may publish in the future.

Co-authorship network of co-authors of Kento Umino

This figure shows the co-authorship network connecting the top 25 collaborators of Kento Umino. A scholar is included among the top collaborators of Kento Umino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kento Umino. Kento Umino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era 2024 ·International Journal of Hematology ·Yumiko Toda, Masahiro Ashizawa, (unknown), (unknown), Takashi Ikeda, Shin‐ichiro Kawaguchi, Takashi Nagayama, Kento Umino, (unknown), Kaoru Morita, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Shin‐ichiro Fujiwara, Ken Ohmine, Yoshinobu Kanda	0
2	Fatty Acids Play a Critical Role in Mitochondrial Oxidative Phosphorylation in Effector T Cells in Graft-versus-Host Disease 2024 ·ImmunoHorizons ·(unknown), Kazuya Sato, (unknown), (unknown), Hiroko Hayakawa, Takashi Ikeda, Shin‐ichiro Kawaguchi, Kiyomi Mashima, Kento Umino, Kaoru Morita, Ryoji Ito, Nobuhiko Ohno, Kaoru Tominaga, Hitoshi Endo, Yoshinobu Kanda	2
3	Forodesine Enhances Immune Responses through Guanosine-Mediated TLR7 Activation while Preventing Graft-versus-Host Disease 2023 ·The Journal of Immunology ·Takashi Ikeda, Kazuya Sato, Shin‐ichiro Kawaguchi, (unknown), (unknown), Hiroko Hayakawa, Kento Umino, Kaoru Morita, Kana Matsumoto, Kentaro Ushijima, Yoshinobu Kanda	4
4	Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation 2022 ·Leukemia Research ·Shin‐ichiro Fujiwara, (unknown), (unknown), (unknown), Takashi Ikeda, Yumiko Toda, Shoko Ito, Shin‐ichiro Kawaguchi, Takashi Nagayama, Kento Umino, (unknown), Kaoru Morita, Hirofumi Nakano, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda	5
5	Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma 2022 ·Annals of Hematology ·Kaoru Hatano, Shin‐ichiro Fujiwara, Kento Umino, Takashi Ikeda, Hirofumi Nakano, Kiyomi Mashima, Shin‐ichiro Kawaguchi, Shoko Ito, Yumiko Toda, Takashi Nagayama, (unknown), Ryoko Yamasaki, Kaoru Morita, Chihiro Yamamoto, Masahiro Ashizawa, Kazuya Sato, Masuzu Ueda, Ken Ohmine, Yoshinobu Kanda	3
6	Mesenchymal Stromal Cells Inhibit Aerobic Glycolysis in Activated T Cells by Negatively Regulating Hexokinase II Activity Through PD-1/PD-L1 Interaction 2020 ·Transplantation and Cellular Therapy ·Yasufumi Kawasaki, Kazuya Sato, Kiyomi Mashima, Hirofumi Nakano, Takashi Ikeda, Kento Umino, Kaoru Morita, (unknown), (unknown), Hiroko Hayakawa, Kaoru Tominaga, Hitoshi Endo, Yoshinobu Kanda	8
7	Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease 2020 ·Bone Marrow Transplantation ·Kaoru Morita, Shin‐ichiro Fujiwara, Takashi Ikeda, Shin‐ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, (unknown), Hirofumi Nakano, Ryoko Yamasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Yoshinobu Kanda	1
8	Dimethyl Fumarate Ameliorates Graft-Versus-Host Disease By Negatively Regulating Aerobic Glycolysis in Alloreactive T-Cells 2020 ·Blood ·Kiyomi Mashima, Kazuya Sato, (unknown), (unknown), Takashi Ikeda, Kento Umino, (unknown), (unknown), Kaoru Morita, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Iekuni Oh, Ken Ohmine, Shin‐ichiro Fujiwara, Yoshinobu Kanda	1
9	Evaluation of thrombotic events in patients with immune thrombocytopenia 2019 ·Annals of Hematology ·Shoko Ito, Shin‐ichiro Fujiwara, Takashi Ikeda, Yumiko Toda, Kiyomi Mashima, Kento Umino, (unknown), Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda	14
10	Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement 2018 ·Hematology ·Kento Umino, Shin‐ichiro Fujiwara, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kiyomi Mashima, (unknown), Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda	20
11	Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse 2018 ·Clinical Lymphoma Myeloma & Leukemia ·Kiyomi Mashima, Iekuni Oh, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kento Umino, (unknown), Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Masahiro Ashizawa, Shin‐ichiro Fujiwara, Kaoru Hatano, Kazuya Sato, (unknown), Kazuo Muroi, Yoshinobu Kanda	12
12	Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome 2018 ·Leukemia & lymphoma ·Kiyomi Mashima, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kento Umino, (unknown), Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Masahiro Ashizawa, Chihiro Yamamoto, Shin‐ichiro Fujiwara, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda	5
13	Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP 2018 ·Leukemia & lymphoma ·Kento Umino, Shin‐ichiro Fujiwara, (unknown), Chihiro Yamamoto, Akiko Meguro, Tomohiro Matsuyama, Kazuya Sato, Ken Ohmine, Tohru Izumi, Kazuo Muroi, Yoshinobu Kanda	7
14	Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia 2017 ·Annals of Hematology ·Shoko Ito, Shin‐ichiro Fujiwara, Kiyomi Mashima, Kento Umino, (unknown), Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kiyoshi Okazuka, Kazuya Sato, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Kazuo Muroi, Yoshinobu Kanda	9
15	High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement 2017 ·Acta Haematologica ·Kento Umino, Shin‐ichiro Fujiwara, Kazuya Sato, (unknown), Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Kaoru Hatano, Kiyoshi Okazuka, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Kazuo Muroi, Yoshinobu Kanda	3
16	Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia 2017 ·International Journal of Hematology ·(unknown), Shin‐ichiro Fujiwara, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kiyomi Mashima, Kento Umino, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda	1
17	Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP 2017 ·Hematology ·Kento Umino, Shin‐ichiro Fujiwara, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kiyomi Mashima, (unknown), Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, (unknown), Yoshinobu Kanda	6
18	A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis 2016 ·Leukemia Research ·(unknown), Shin‐ichiro Fujiwara, Shoko Ito, Kiyomi Mashima, Kento Umino, Hirofumi Nakano, Yasufumi Kawasaki, Miyuki Sugimoto, Ryoko Yamasaki, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kiyoshi Okazuka, Kazuya Sato, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, (unknown), Yoshinobu Kanda	10
19	Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan 2016 ·Annals of Hematology ·Miyuki Sugimoto, Shoko Ito, Kiyomi Mashima, Kento Umino, (unknown), Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Masahiro Ashizawa, Chihiro Yamamoto, Shin‐ichiro Fujiwara, Kiyoshi Okazuka, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Kazuo Muroi, Shinichi Kako, Yoshinobu Kanda	14
20	Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia 2016 ·Leukemia & lymphoma ·Chihiro Yamamoto, Shoko Ito, Kiyomi Mashima, Kento Umino, (unknown), Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Hirofumi Nakano, Masahiro Ashizawa, Kiyoshi Okazuka, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Shin‐ichiro Fujiwara, Ken Ohmine, Takahiro Suzuki, Kazuo Muroi, Yoshinobu Kanda	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact